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Introduction: Gastrointestinal tract soft tissues metastasis is a well-known occurrence with invasive lobular breast
cancer subtypes. Gastric involvement is more common, with reports of both diffuse and localized involvements.
Usually, a gastric localized involvement presents as wall thickening with an appearance similar to that of a
gastrointestinal stromal tumour; rarely does a localized metastatic deposit grow aggressively to present as a large
tumour causing obstructive symptoms. Our case highlights one such unusual presentation in a patient presenting
with non-specific gastrointestinal symptoms. To the best of our knowledge, there have been no previous reports
on a similar presentation occurring from a localized metastasis.
Case presentation: A 65-year-old Caucasian woman awaiting an outpatient oral gastroduodenoscopy for
symptoms of intermittent vomiting, epigastric pains and weight loss of six weeks’ duration presented acutely with
symptoms of haematemesis and abdominal distension. An initial contrast-enhanced computed tomography scan
showed a grossly dilated stomach with a locally advanced stenosing tumour mass at the pylorus. Our patient had a
history of left mastectomy and axillary clearance followed by adjuvant endocrine therapy for an oestrogen receptor-
and progesterone receptor-positive, grade 2, invasive lobular breast cancer. The oral gastroduodenoscopy
confirmed the computed tomography findings; biopsies of the pyloric mass on immunohistochemistry stains were
strongly positive for pancytokeratin and gross cystic disease fluid proteins, consistent with an invasive lobular breast
cancer metastasis. She received a palliative gastrojejunal bypass and her adjuvant endocrine treatment was
switched over to exemestane.
Conclusion: Our case highlights the aggressive behaviour of a localized gastric metastasis that is unusual and
unexpected. Gastrointestinal symptomatology can be non-specific and, at times, non-diagnostic on conventional
mucosal biopsies. A high index of clinical suspicion in patients with a previous history of invasive lobular breast
cancer can aid in an early diagnosis and treatment. A combined treatment approach with chemoendocrine
therapies achieves remission and improves patient survival.Introduction
Distant metastasis with breast cancer to the bone, lung,
brain and vulva is a known occurrence; intra-abdominal
involvement is commonly seen with the intralobular
histological subtype [1-3]. Clinical presentations are var-
ied, depending on a diffuse or localized involvement. A
localized presentation usually causes a segmental thick-
ening of the involved soft tissues; by contrast, diffuse
infiltrations cause bowel stricturing and present as
obstructions. We report an unusual presentation of a* Correspondence: tasadooq.hussain@gmail.com
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breast cancer (ILC) presenting with gastric obstruction.Case presentation
A 65-year-old Caucasian woman with a history of ongoing
intermittent vomiting, epigastric pains and weight loss of
six weeks duration presented to our acute admissions unit
with symptoms of haematemesis and abdominal disten-
sion. She was admitted with similar complaints a week
before and was awaiting an outpatient oral gastroduodeno-
scopy examination. Her past history was significant for
having had a left mastectomy and axillary clearance fol-
lowed by adjuvant endocrine therapy for a node-positive,
oestrogen receptor (ER)-positive, progesterone receptorl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Gross distension of the stomach extending into the
pelvis.
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(HER 2)-negative grade 2 ILC. On her routine follow-ups
she was found to be free of any recurrence on clinical and
radiological examination.
From her acute presentation, a clinical impression of a
possible gastric or a high grade small bowel obstruction
was made from the findings of a large gastric gas bubble
on an X-ray of her chest. A contrast-enhanced computer
tomography (CT) scan showed a grossly dilated stomach
up to her pelvis with a locally advanced stenosing tumour
mass at the pylorus (Figures 1 and 2). CT findings were
confirmed on oral endoscopy with a perceived difficulty to
advance the scope beyond her pylorus. Gastric biopsies
from the tumour mass were taken and our patient com-
menced on parental nutrition. Histology from the biopsy
specimen showed groups of atypical epithelial cells in small
clusters, which on immunohistochemistry stain were
strongly positive for pancytokeratin and gross cystic disease
fluid proteins (GCDFP). A formal identification of protein
receptor status (ER, PR and HER2) and Ki67 index on gas-
tric biopsies specimens was deemed not necessary given
the strong positivity to the GCDFP, a feature strongly con-
sistent with ILC pathology. Following discussion at upper
gastrointestinal (GI) and breast multi-disciplinary meet-
ings, GI symptoms were palliated with a gastrojejunal by-
pass and the adjuvant endocrine treatment was switched
over to exemestane.
Discussion
ILC amongst all other invasive types is more commonly
associated with GI metastasis [1]. The occurrences can in-
volve any organ system starting from the oesophagus to
the rectum [2]. The intra-abdominal organ involvements,
in the order of increasing rarity include stomach, colon,
rectum and small bowel. Occasionally, gastric metastasis
involves peritoneum, adrenals and lung pleura presenting
as primary carcinomatosis [3]. Ureteral obstructions areFigure 1 Computed tomography contrast image showing
gastric outlet obstruction.common presentations with retroperitoneal involvement
[4]. Women affected have a median age of 55 years, with a
reported mean interval of 7 years for a metastatic presenta-
tion from the time of primary diagnosis.
The initial clinical presentation can be with a primary
disease or with a metastatic involvement. Usually, the
breast cancer diagnosis precedes signs of metastatic pro-
gression; however, a few reports on occult breast cancer
disease presenting with initial symptoms of metastatic
spread have also been reported [4]. Gastric metastasis usu-
ally presents with non-specific symptoms of anorexia,
vomiting, epigastric pain and - rarely - fatal haemorrhage.
Endoscopy findings with diffuse gastric infiltration can
mimic features of linitis plastica type infiltration, resem-
bling a gastric malignancy; localized infiltration presents as
small polyps that infrequently grow larger to resemble a
gastrointestinal stromal tumour accept. Bowel involvement
usually results in an obstructive pathology from the stric-
turing of the lumen with metastatic infiltration; occasion-
ally, non-specific symptoms of diarrhoea and abdominal
cramps precede a palpable growth [2]. Very rarely, patients
can present with features of jaundice with biliary involve-
ment from a metastatic occlusion of the distal bile ducts or
duodenal infiltration [5].
The histological features of ILC are characterised by the
presence of discohesive cells arranged in small clusters
with a low grade nuclear pleomorphism and the absence of
a stromal desmoplastic response allowing differentiation
[6]. Immunohistochemistry staining for specific markers
like ER, PR, cytokeratin 5 and/or 6 and GCDFP is found to
be highly specific (P < 0.001, P=0.002, P < 0.001 and
P=0.004, respectively) [6]. A further validation of the use
of immunosensitivity in making an accurate pathological
diagnosis comes from the immunoanalysis studies by van
Velthuysen et al. [7]: a strong positive staining for new
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tive E-cadherin (P < 0.001) help differentiate this condition
from gastric adenocarcinoma.
Clinicians involved in the management of this disease
should be aware of the limitations of endoscopic biopsies
in excluding metastasis because of a high false negative rate
from the relatively late involvement of the avascular muco-
sal layers with metastasis. Therefore, non-conventional
techniques, like macro-biopsies or endoscopic ultrasound-
guided fine needle aspiration cytology, should be employed
in cases where there is a high index of clinical suspicion [3]
for accurate diagnosis. The presence of non-specific GI
symptomatology can usually delay the diagnosis as rarely
does a localized deposit grow aggressively enough to cause
obstruction of the hollow viscus. Both these features seen
in our case were new and not consistent with any previ-
ously published reports. Therefore, clinicians attending to
patients with a history of lobular disease should have a high
index of suspicion for this diagnosis to prompt an early in-
vestigation before the patient progresses and the metastasis
becomes obstructive. Medical management with systemic
chemo- or endocrine therapy with or without radiation can
yield better survival outcomes in young patients with non-
obstructive presentations [3-7]. Surgery is usually reserved
to palliate symptoms of obstruction, bleeding and perfor-
ation. However, the overall prognosis at a progressed stage
from most of the reported case series is rather poor, with a
predicted median survival of only 2 years from the time of
diagnosis [3].
The surgical management of our patient was largely
guided by her widespread intra-abdominal dissemination.
Post-surgery, keeping in line with our clinical practice, the
decision to switch her adjuvant treatment to exemestane
was taken based on the previous ER-positive status of her
breast cancer. Given our patient’s gastric biopsy specimen
was strongly positivity for the GCDFP, which have a high
specificity in primary lobular breast carcinoma and meta-
static carcinoma of suspected breast origin [8], a routine
screening for ER and PR status was deemed not necessary
for the confirmation of the diagnosis or the adjuvant deci-
sion making.
Recent studies on tumour progression based on molecu-
lar characteristics have found breast tumour cells to have
cancer stem cell properties regulated by HER2 protein.
Studies concluded that HER2 overexpression increase the
proliferation and survival of the primary tumour and have
a role to play in the distant metastasis by transformation
of breast tumour cells to cancer stem cells [9], thereby fa-
cilitating their migration. However, in our case, the tumour
progression cannot be convincingly explained on this basis
alone given the negative HER2 status of the original breast
primary tumour. Both ILC and the invasive ductal cancer
(IDC) subtypes have different tumour biologies explaining
their metastatic patterns. Whilst IDC favour metastasisingto bone, lung and liver, ILC commonly metastasises to the
GI tract, lung pleura, brain and spinal cord. This behav-
iour, as explained by various studies, is due to the small
size and shape of ILC cells, with E-cadherin overexpres-
sion favouring discohesiveness between the cells to mi-
grate to areas of microanatomy more conducive to
stopping these cells [10,11]. Alternatively, the microenvir-
onment of the ovary or peritoneum may provide growth
and survival factors that favour ILC cells over IDC cells,
explaining the difference in the metastatic pattern between
the two subtypes [12].
Conclusions
Although gastric metastasis with ILC is a known occur-
rence, the rapid progression of a localized deposit leading
to obstructive symptoms is an unusual and unexpected
presentation of the disease. A high index of clinical suspi-
cion in these patients warrants a thorough investigation of
all early non-specific GI symptoms. An early diagnosis and
a combined treatment approach are helpful in improving
the remission and patient survival.
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